Matches in Wikidata for { <http://www.wikidata.org/entity/Q90015940> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q90015940 description "article scientifique publié en 2019" @default.
- Q90015940 description "artículu científicu espublizáu en payares de 2019" @default.
- Q90015940 description "scientific article published on 04 November 2019" @default.
- Q90015940 description "wetenschappelijk artikel" @default.
- Q90015940 description "наукова стаття, опублікована 4 листопада 2019" @default.
- Q90015940 name "Cost-effectiveness of ranibizumab and aflibercept to treat diabetic macular edema from a US perspective: analysis of 2-year Protocol T data" @default.
- Q90015940 name "Cost-effectiveness of ranibizumab and aflibercept to treat diabetic macular edema from a US perspective: analysis of 2-year Protocol T data" @default.
- Q90015940 type Item @default.
- Q90015940 label "Cost-effectiveness of ranibizumab and aflibercept to treat diabetic macular edema from a US perspective: analysis of 2-year Protocol T data" @default.
- Q90015940 label "Cost-effectiveness of ranibizumab and aflibercept to treat diabetic macular edema from a US perspective: analysis of 2-year Protocol T data" @default.
- Q90015940 prefLabel "Cost-effectiveness of ranibizumab and aflibercept to treat diabetic macular edema from a US perspective: analysis of 2-year Protocol T data" @default.
- Q90015940 prefLabel "Cost-effectiveness of ranibizumab and aflibercept to treat diabetic macular edema from a US perspective: analysis of 2-year Protocol T data" @default.
- Q90015940 P1433 Q90015940-296E520D-51B5-427E-AE77-00800CFCEDF2 @default.
- Q90015940 P1476 Q90015940-E3019388-24CA-4583-A904-576312C6A36D @default.
- Q90015940 P2093 Q90015940-0F0BD370-B30B-4D9E-9E34-F6F0CD42DB52 @default.
- Q90015940 P275 Q90015940-179E8D3E-5CB9-4823-A59F-08C55CECA27A @default.
- Q90015940 P304 Q90015940-9FDDD210-F5B6-4E7F-8A2F-0AFEB88E7DD7 @default.
- Q90015940 P31 Q90015940-E10DF67E-E2A7-4826-AFBF-6CC16B735DA3 @default.
- Q90015940 P356 Q90015940-7FBBFC8B-0625-4B17-A825-10BEE4203CDA @default.
- Q90015940 P433 Q90015940-0986E9CB-00E2-41A0-AF18-34EA024B2F8B @default.
- Q90015940 P478 Q90015940-66321118-40AF-493D-8520-7FDE2AA94EEB @default.
- Q90015940 P50 Q90015940-21C4259F-104D-4D0D-A45A-17A7948EE2A1 @default.
- Q90015940 P50 Q90015940-BF6FDC21-4D93-4B6D-8F91-FB11538D99FB @default.
- Q90015940 P50 Q90015940-D21F2527-FF82-42C7-80CA-DA9A64F81A9D @default.
- Q90015940 P577 Q90015940-ECFFFA68-4D02-4AB8-9E08-3506BB5295B8 @default.
- Q90015940 P6216 Q90015940-AC33F57E-386F-4805-863B-D26602548B15 @default.
- Q90015940 P698 Q90015940-C26EA428-3843-4225-A2D5-9F9095BF311A @default.
- Q90015940 P921 Q90015940-250A990F-3203-4AF8-81F5-C6AB417C7D87 @default.
- Q90015940 P921 Q90015940-D0B83CD5-1267-4AD5-BDA6-7F2217DD228D @default.
- Q90015940 P356 13696998.2019.1666855 @default.
- Q90015940 P698 31502893 @default.
- Q90015940 P1433 Q6295521 @default.
- Q90015940 P1476 "Cost-effectiveness of ranibizumab and aflibercept to treat diabetic macular edema from a US perspective: analysis of 2-year Protocol T data" @default.
- Q90015940 P2093 "Yamina Rajput" @default.
- Q90015940 P275 Q24082749 @default.
- Q90015940 P304 "287-296" @default.
- Q90015940 P31 Q13442814 @default.
- Q90015940 P356 "10.1080/13696998.2019.1666855" @default.
- Q90015940 P433 "3" @default.
- Q90015940 P478 "23" @default.
- Q90015940 P50 Q90015930 @default.
- Q90015940 P50 Q90015933 @default.
- Q90015940 P50 Q90015937 @default.
- Q90015940 P577 "2019-11-04T00:00:00Z" @default.
- Q90015940 P6216 Q50423863 @default.
- Q90015940 P698 "31502893" @default.
- Q90015940 P921 Q18558081 @default.
- Q90015940 P921 Q4689286 @default.